Dopaminergic agents (anti-parkinson drug)

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	60.74%
INSURED CONSUMERS
% of insured consumers	0.69%
Median age	75 years
Max/min ratio of the median age (by district)	1.10
Percentage of women	55.34%
Ratio Preferential scheme/General scheme	1.93
Coefficient of variation (2022)	19.53
Max/min ratio of % of insured consumers (by district)	3.20
CONSUMPTION
Annual consumption (DDD)	18,683,806
Consumption of DDD (per 100,000 insured persons)	162,919.86
% DDD issued outside the insurance (approximate)	4.27%
Average annual consumption per insured consumer (DDD)	237.47
% of insured consumers with > 3 times the average consumption	8.86%
Coefficient of variation (% of insured consumers) 2012-2014	17.24
Coefficient of variation (% of insured consumers) 2020-2022	18.07
Trend 2012-2022	0.18%
Trend 2012-2019	0.69%
Trend 2019-2022	-0.99%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	21,353,119€
Average annual expenditure per insured person	1.86 €
Average patient share per insured consumer	17.23%
Max/min ratio of expenditure per insured person (by disctrict)	2.04
% “Low-cost” medication	90.17%
Trend 2012-2022	-4.19%
Trend 2019-2022	-2.37%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - ATC codes selected for analysis Click to collapse

CODES (ATC-5)	LABELS
N04BA	DOPA AND DOPA DERIVATIVES
N04BB	ADAMANTANE DERIVATIVES
N04BC	DOPAMINE AGONISTS
N04BD	MONOAMINE OXIDASE B INHIBITORS
N04BX	OTHER DOPAMINERGIC AGENTS